Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Brain & nervous system
Sign up for latest coverage
Submit your event
cancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Prevention & screening
Middle East and North Africa
Central America and the Caribbean
Australia and Oceania
2015 ASCO Annual Meeting
29 May - 2 Jun 2015
McCormick Place, Chicago, United States of America
New trial will link targeted cancer drugs to gene abnormalities
Oral cancer therapy combination prevents progression of advanced melanoma for over a year
Study demonstrates survival benefits of immunotherapy MPDL3280A for lung cancer patients compared wi...
European Commission grants marketing authorization for lenvatinib in advanced RAI-refractory differe...
ASCO 2015: Pembrolizumab may be promising treatment for urothelial cancer
ASCO 2015: MEDI4736 tremelimumab combo shows activity in NSCLC
ASCO 2015: Phase III study finds initial nivolumab-based treatment halts melanoma progression
ASCO 2015: Improved care has extended the lifespan of childhood cancer survivors since the 1970s
ASCO 2015: Preventive neck lymph node surgery improves early oral cancer survival
ASCO 2015: Risks of adjuvant whole brain radiation therapy outweigh benefits for patients with limit...
ASCO 2015: First effective adjuvant chemotherapy for high-risk, localised prostate cancer
ASCO 2015: Extensive lymph node surgery may not be necessary for some patients with melanoma
ASCO 2015: First-in-class targeted drug daratumumab shows promise in heavily treatment-resistant mul...
ASCO 2015: Anastrazole offers higher breast cancer-free survival rates than tamoxifen following DCIS
ASCO 2015: Novel targeted drug palbociclib slows progression of hormone receptor-positive breast can...
ASCO 2015: Obinutuzumab doubles remission duration in patients with relapsed, indolent non-hodgkin l...
ASCO 2015: New ibrutinib combination regimen shows substantial benefits in relapsed chronic lymphocy...
ASCO 2015: Novel JAK inhibitor pacritinib proves effective for easing symptoms of myelofibrosis
ASCO 2015: Eribulin extends overall survival for patients with advanced liposarcoma and leiomyosarco...
ASCO 2015: Nivolumab shows highly promising activity in advanced liver cancer in early-stage trial
ASCO 2015: Pembrolizumab shows promising activity against head and neck cancer
ASCO 2015: Nivolumab extends survival for patients with the most common lung cancer
ASCO 2015: Genomic marker predicts anti-PD-1 response in several cancers
ASCO 2015: Adding chemotherapy to initial therapy extends lives of men with advanced, hormone-naïve ...
ASCO 2015: Augmenting standard therapies increases cure rates for high-risk wilms tumour
ASCO 2015: Adding elotuzumab significantly reduces risk of progression for relapsed multiple myeloma
ASCO 2015: Simple oral vitamin reduces risk of common, non-melanoma skin cancers